252 related articles for article (PubMed ID: 10472443)
1. [Therapeutic failure of melarsoprol among patients treated for late stage T.b. gambiense human African trypanosomiasis in Uganda].
Legros D; Fournier C; Gastellu Etchegorry M; Maiso F; Szumilin E
Bull Soc Pathol Exot; 1999 Jul; 92(3):171-2. PubMed ID: 10472443
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of a 10-day melarsoprol schedule for the treatment of late-stage human African trypanosomiasis: confirmation from a multinational study (IMPAMEL II).
Schmid C; Richer M; Bilenge CM; Josenando T; Chappuis F; Manthelot CR; Nangouma A; Doua F; Asumu PN; Simarro PP; Burri C
J Infect Dis; 2005 Jun; 191(11):1922-31. PubMed ID: 15871127
[TBL] [Abstract][Full Text] [Related]
3. Eflornithine is safer than melarsoprol for the treatment of second-stage Trypanosoma brucei gambiense human African trypanosomiasis.
Chappuis F; Udayraj N; Stietenroth K; Meussen A; Bovier PA
Clin Infect Dis; 2005 Sep; 41(5):748-51. PubMed ID: 16080099
[TBL] [Abstract][Full Text] [Related]
4. Genotypic and phenotypic characterization of Trypanosoma brucei gambiense isolates from Ibba, South Sudan, an area of high melarsoprol treatment failure rate.
Maina N; Maina KJ; Mäser P; Brun R
Acta Trop; 2007; 104(2-3):84-90. PubMed ID: 17765860
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for treatment failure after melarsoprol for Trypanosoma brucei gambiense trypanosomiasis in Uganda.
Legros D; Evans S; Maiso F; Enyaru JC; Mbulamberi D
Trans R Soc Trop Med Hyg; 1999; 93(4):439-42. PubMed ID: 10674099
[TBL] [Abstract][Full Text] [Related]
6. The phenomenon of treatment failures in Human African Trypanosomiasis.
Brun R; Schumacher R; Schmid C; Kunz C; Burri C
Trop Med Int Health; 2001 Nov; 6(11):906-14. PubMed ID: 11703845
[TBL] [Abstract][Full Text] [Related]
7. Combination chemotherapy with a substance P receptor antagonist (aprepitant) and melarsoprol in a mouse model of human African trypanosomiasis.
Rodgers J; Bradley B; Kennedy PG
Parasitol Int; 2007 Dec; 56(4):321-4. PubMed ID: 17643344
[TBL] [Abstract][Full Text] [Related]
8. Novel markers for treatment outcome in late-stage Trypanosoma brucei gambiense trypanosomiasis.
Lejon V; Roger I; Mumba Ngoyi D; Menten J; Robays J; N'siesi FX; Bisser S; Boelaert M; Büscher P
Clin Infect Dis; 2008 Jul; 47(1):15-22. PubMed ID: 18494605
[TBL] [Abstract][Full Text] [Related]
9. Randomized, controlled trial of treatments for second-stage sleeping sickness.
Woodrow CJ; Abel PM; Krishna S
J Infect Dis; 2007 Aug; 196(4):650-1. PubMed ID: 17624857
[No Abstract] [Full Text] [Related]
10. Effectiveness of melarsoprol and eflornithine as first-line regimens for gambiense sleeping sickness in nine Médecins Sans Frontières programmes.
Balasegaram M; Young H; Chappuis F; Priotto G; Raguenaud ME; Checchi F
Trans R Soc Trop Med Hyg; 2009 Mar; 103(3):280-90. PubMed ID: 18947846
[TBL] [Abstract][Full Text] [Related]
11. Clinical presentation and treatment outcome of sleeping sickness in Sudanese pre-school children.
Eperon G; Schmid C; Loutan L; Chappuis F
Acta Trop; 2007 Jan; 101(1):31-9. PubMed ID: 17207760
[TBL] [Abstract][Full Text] [Related]
12. [Human African trypanosomiasis in Ivory Coast: biological characteristics after treatment. 812 cases treated in the Daloa focus (Ivory Coast)].
Miezan TW; Dje NN; Doua F; Boa F
Bull Soc Pathol Exot; 2002 Dec; 95(5):362-5. PubMed ID: 12696377
[TBL] [Abstract][Full Text] [Related]
13. [Melarsoprol].
Simon F
Med Trop (Mars); 1999; 59(4):331-2. PubMed ID: 10816741
[No Abstract] [Full Text] [Related]
14. Control of human African trypanosomiasis in the Quiçama focus, Angola.
Ruiz JA; Simarro PP; Josenando T
Bull World Health Organ; 2002; 80(9):738-45. PubMed ID: 12378293
[TBL] [Abstract][Full Text] [Related]
15. Sleep structure: a new diagnostic tool for stage determination in sleeping sickness.
Buguet A; Bisser S; Josenando T; Chapotot F; Cespuglio R
Acta Trop; 2005 Jan; 93(1):107-17. PubMed ID: 15589803
[TBL] [Abstract][Full Text] [Related]
16. [Human African trypanosomiasis, contributions of experimental models].
Bouteille B; Millet P; Enanga B; Mezui Me J; Keita M; Jauberteau MO; Georges A; Dumas M
Bull Soc Pathol Exot; 1998; 91(2):127-32. PubMed ID: 9642464
[TBL] [Abstract][Full Text] [Related]
17. Arsenicals (melarsoprol), pentamidine and suramin in the treatment of human African trypanosomiasis.
Nok AJ
Parasitol Res; 2003 May; 90(1):71-9. PubMed ID: 12743807
[TBL] [Abstract][Full Text] [Related]
18. Melarsoprol-free drug combinations for second-stage Gambian sleeping sickness: the way to go.
Chappuis F
Clin Infect Dis; 2007 Dec; 45(11):1443-5. PubMed ID: 17990226
[No Abstract] [Full Text] [Related]
19. Melarsoprol refractory T. b. gambiense from Omugo, north-western Uganda.
Matovu E; Enyaru JC; Legros D; Schmid C; Seebeck T; Kaminsky R
Trop Med Int Health; 2001 May; 6(5):407-11. PubMed ID: 11348535
[TBL] [Abstract][Full Text] [Related]
20. [Arsenical resistance and difluoromethylornithine in the treatment of human African trypanosomiasis].
Kazyumba GL; Ruppol JF; Tshefu AK; Nkanga N
Bull Soc Pathol Exot Filiales; 1988; 81(3 Pt 2):591-4. PubMed ID: 3143492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
